How to better mobilise public and private investment for healthy ageing innovation at European scale?

The growing awareness on the needs and opportunities brought by an extended lifespan raises the challenge of financing the deployment and development of innovative solutions. While the main investment sources in innovation for healthy ageing depend on the public sector, how can governments stimulate private players to finance innovative projects? What investments are being made today in Europe and what types of investors are involved? Which funding instruments to create new synergies between public and private investors and leverage the funds’ destination and impact?